Turnstone Biologics Corp. (TSBX)
Aug 11, 2025 - TSBX was delisted (reason: acquired by XOMA)
0.3550
0.00 (0.00%)
Inactive · Last trade price
on Aug 8, 2025
TSBX's stock price has decreased by -83.6% in the past year and price targets may not have had time to catch up.
Turnstone Biologics Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$4.75
Upside
+1,238.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $10 → $0.5 | Strong Buy → Hold | Downgrades | $10 → $0.5 | +40.85% | Oct 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +2,716.90% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $3.75 | Buy | Maintains | $20 → $3.75 | +956.34% | Aug 19, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +4,970.42% | Aug 15, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $20 | Buy | Initiates | $20 | +5,533.80% | Aug 15, 2023 |